Chinese General Practice ›› 2023, Vol. 26 ›› Issue (21): 2614-2619.DOI: 10.12114/j.issn.1007-9572.2022.0735
Special Issue: 胰腺炎最新文章合集
• Original Research • Previous Articles Next Articles
Received:
2022-06-13
Revised:
2022-11-09
Published:
2023-07-20
Online:
2022-11-27
Contact:
ZHAO Ping
通讯作者:
赵平
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0735
组别 | 例数 | 年龄( | 性别(男/女) | 高血压〔n(%)〕 | 糖尿病〔n(%)〕 | 高脂血症〔n(%)〕 | 胆管疾病史〔n(%)〕 | BMI ( |
---|---|---|---|---|---|---|---|---|
AP组 | 100 | 45.4±15.3 | 76/24 | 29(29.0) | 21(21.0) | 43(43.0) | 23(23.0) | 26.3±3.1 |
非AP组 | 100 | 43.2±13.5 | 68/32 | 26(26.0) | 19(19.0) | 25(25.0) | 17(17.0) | 23.6±2.2 |
χ2(t)值 | 1.267a | 1.587 | 0.226 | 0.125 | 7.219 | 1.125 | 9.754a | |
P值 | 0.205 | 0.208 | 0.635 | 0.724 | 0.007 | 0.289 | <0.001 |
Table 1 Comparison of clinical data between acute pancreatitis group and non-acute pancreatitis group
组别 | 例数 | 年龄( | 性别(男/女) | 高血压〔n(%)〕 | 糖尿病〔n(%)〕 | 高脂血症〔n(%)〕 | 胆管疾病史〔n(%)〕 | BMI ( |
---|---|---|---|---|---|---|---|---|
AP组 | 100 | 45.4±15.3 | 76/24 | 29(29.0) | 21(21.0) | 43(43.0) | 23(23.0) | 26.3±3.1 |
非AP组 | 100 | 43.2±13.5 | 68/32 | 26(26.0) | 19(19.0) | 25(25.0) | 17(17.0) | 23.6±2.2 |
χ2(t)值 | 1.267a | 1.587 | 0.226 | 0.125 | 7.219 | 1.125 | 9.754a | |
P值 | 0.205 | 0.208 | 0.635 | 0.724 | 0.007 | 0.289 | <0.001 |
组别 | 例数 | SAT面积(cm2) | VAT面积(cm2) | TAT面积(cm2) | VAT/SAT | VAT/TAT |
---|---|---|---|---|---|---|
AP组 | 100 | 125.33±23.18 | 205.20±18.88 | 330.54±41.86 | 1.68±0.27 | 0.62±0.03 |
非AP组 | 100 | 119.90±20.20 | 160.40±22.23 | 280.30±42.27 | 1.34±0.05 | 0.57±0.01 |
t值 | 1.767 | 15.362 | 8.445 | 12.292 | 17.592 | |
P值 | 0.079 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 2 Comparison of CT-assessed abdominal fat content and distribution between acute pancreatitis group and non-acute pancreatitis group
组别 | 例数 | SAT面积(cm2) | VAT面积(cm2) | TAT面积(cm2) | VAT/SAT | VAT/TAT |
---|---|---|---|---|---|---|
AP组 | 100 | 125.33±23.18 | 205.20±18.88 | 330.54±41.86 | 1.68±0.27 | 0.62±0.03 |
非AP组 | 100 | 119.90±20.20 | 160.40±22.23 | 280.30±42.27 | 1.34±0.05 | 0.57±0.01 |
t值 | 1.767 | 15.362 | 8.445 | 12.292 | 17.592 | |
P值 | 0.079 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | SAT面积(cm2) | VAT面积(cm2) | TAT面积(cm2) | VAT/SAT | VAT/TAT |
---|---|---|---|---|---|---|
非重症AP亚组 | 75 | 126.53±17.82 | 178.74±20.51 | 305.26±37.77 | 1.42±0.09 | 0.59±0.01 |
重症AP亚组 | 25 | 130.59±15.48 | 243.39±18.76 | 373.98±34.01 | 1.87±0.10 | 0.65±0.01 |
t值 | -1.019 | -13.932 | -8.068 | -21.677 | -21.108 | |
P值 | 0.311 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 3 Comparison of CT-assessed abdominal fat content and distribution between severe and non-severe acute pancreatitis subgroups
组别 | 例数 | SAT面积(cm2) | VAT面积(cm2) | TAT面积(cm2) | VAT/SAT | VAT/TAT |
---|---|---|---|---|---|---|
非重症AP亚组 | 75 | 126.53±17.82 | 178.74±20.51 | 305.26±37.77 | 1.42±0.09 | 0.59±0.01 |
重症AP亚组 | 25 | 130.59±15.48 | 243.39±18.76 | 373.98±34.01 | 1.87±0.10 | 0.65±0.01 |
t值 | -1.019 | -13.932 | -8.068 | -21.677 | -21.108 | |
P值 | 0.311 | <0.001 | <0.001 | <0.001 | <0.001 |
变量 | 赋值 |
---|---|
AP | 0=否,1=是 |
AP严重程度 | 0=非重症AP,1=重症AP |
高脂血症 | 0=否,1=是 |
BMI | 0=<28 kg/m2,1=≥28 kg/m2 |
VAT面积 | 实测值 |
TAT面积 | 实测值 |
VAT/SAT | 实测值 |
VAT/TAT | 实测值 |
Table 4 Assignment table for factors associated with acute pancreatitis and its severity identified using multivariate Logistic regression
变量 | 赋值 |
---|---|
AP | 0=否,1=是 |
AP严重程度 | 0=非重症AP,1=重症AP |
高脂血症 | 0=否,1=是 |
BMI | 0=<28 kg/m2,1=≥28 kg/m2 |
VAT面积 | 实测值 |
TAT面积 | 实测值 |
VAT/SAT | 实测值 |
VAT/TAT | 实测值 |
变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
高脂血症 | -0.689 | 0.352 | 3.819 | 0.051 | 0.502 | (0.252,1.002) |
BMI | 0.686 | 0.105 | 42.693 | <0.001 | 1.985 | (1.616,2.438) |
VAT面积 | 0.119 | 0.017 | 46.934 | <0.001 | 1.126 | (1.088,1.165) |
TAT面积 | 0.028 | 0.005 | 35.260 | <0.001 | 1.028 | (1.019,1.038) |
VAT/SAT | 119.501 | 70.216 | 2.896 | 0.089 | 7.918E51 | (0,4.65E111) |
VAT/TAT | 99.925 | 33.584 | 8.853 | 0.095 | 2.494E43 | (6.464E14,9.621E71) |
Table 5 Multivariate Logistic regression analysis of factors associated with acute pancreatitis
变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
高脂血症 | -0.689 | 0.352 | 3.819 | 0.051 | 0.502 | (0.252,1.002) |
BMI | 0.686 | 0.105 | 42.693 | <0.001 | 1.985 | (1.616,2.438) |
VAT面积 | 0.119 | 0.017 | 46.934 | <0.001 | 1.126 | (1.088,1.165) |
TAT面积 | 0.028 | 0.005 | 35.260 | <0.001 | 1.028 | (1.019,1.038) |
VAT/SAT | 119.501 | 70.216 | 2.896 | 0.089 | 7.918E51 | (0,4.65E111) |
VAT/TAT | 99.925 | 33.584 | 8.853 | 0.095 | 2.494E43 | (6.464E14,9.621E71) |
变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
高脂血症 | -0.270 | 0.464 | 0.339 | 0.560 | 0.763 | (0.307,1.895) |
BMI | 2.021 | 0.548 | 13.585 | <0.001 | 7.543 | (2.576,22.088) |
VAT面积 | 28.462 | 321.477 | 0.008 | 0.929 | 2.295E12 | (0,1.000E286) |
TAT面积 | 0.072 | 0.017 | 17.216 | <0.001 | 1.074 | (1.038,1.111) |
VAT/SAT | 101.859 | 97.503 | 1.091 | 0.296 | 1.725E44 | (0,1.704E127) |
VAT/TAT | 311.407 | 146.892 | 4.494 | 0.299 | 1.740E135 | (1.613E10,1.890E260) |
Table 6 Multivariate Logistic regression analysis of factors associated with the severity of acute pancreatitis
变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
高脂血症 | -0.270 | 0.464 | 0.339 | 0.560 | 0.763 | (0.307,1.895) |
BMI | 2.021 | 0.548 | 13.585 | <0.001 | 7.543 | (2.576,22.088) |
VAT面积 | 28.462 | 321.477 | 0.008 | 0.929 | 2.295E12 | (0,1.000E286) |
TAT面积 | 0.072 | 0.017 | 17.216 | <0.001 | 1.074 | (1.038,1.111) |
VAT/SAT | 101.859 | 97.503 | 1.091 | 0.296 | 1.725E44 | (0,1.704E127) |
VAT/TAT | 311.407 | 146.892 | 4.494 | 0.299 | 1.740E135 | (1.613E10,1.890E260) |
[1] |
|
[2] |
中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华消化外科杂志,2021,20(7):730-739. DOI:10.3760/cma.j.cn115610-20210622-00297.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
中华医学会消化病学分会胰腺疾病学组. 中国急性胰腺炎诊治指南(2019年,沈阳)[J].中华消化杂志,2019,39(11):721-730. DOI:10.3760/cma.j.issn.0254-1432.2019.11.001.
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[1] | NAN Ziqing, LIN li. Progress in the Diagnosis and Treatment of Urinary Retention during Pregnancy [J]. Chinese General Practice, 2023, 26(36): 4608-4612. |
[2] | Expert Consensus Writing Group of Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease. Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition) [J]. Chinese General Practice, 2023, 26(35): 4359-4371. |
[3] | HONG Yuchun, WU Hua, DU Yishan, LI Shuran, SUN Wenmin, YE Mingyu, ZHANG Yongjian, LI Yang. Development of General Practice Diagnostic Terminology and Coding and Empirical Study on Its Application [J]. Chinese General Practice, 2023, 26(31): 3896-3901. |
[4] | WANG Zhen, SHEN Guoqi, LI Yanan, ZHU Yinghua, QIU Hang, ZHENG Di, XU Tongda, LI Wenhua. Development and Validation of a Risk Prediction Model for Contrast-induced Acute Kidney Injury after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(29): 3650-3656. |
[5] | CHEN Jing, ZOU Tao, ZHAO Danqing, XIAO Ziwen, WU Xianqing, Chinese Medical Association Psychosomatic Medicine Branch Perinatal Mental Disorders Collaborative Group. Expert Consensus on Screening, Diagnosis and Treatment of Perinatal Mental Disorders [J]. Chinese General Practice, 2023, 26(28): 3463-3470. |
[6] | Expert group of expert consensus on the application of ulinastatin in common clinical critical illness. Expert Consensus on the Application of Ulinastatin in Common Clinical Critical Illness [J]. Chinese General Practice, 2023, 26(26): 3207-3219. |
[7] | LI Zimeng, WANG Rong, CHEN Shuai, ZHAO Caili, WANG Xiaocong, WEN Yalu, LIU Long. Application of metaPRS and APOEε4 to Optimize Genetic Risk Prediction Modeling Strategy for Mild Cognitive Impairment [J]. Chinese General Practice, 2023, 26(25): 3104-3111. |
[8] | YIN Zhaoxia, KONG Chongyu, ZOU Xianhui, LI Chuang, HUANG Yin, FENG Yang, WANG Yunfei, GONG Weijie. Traditional Chinese Medicine Disease Spectrum Analysis in Outpatient Clinics of Contracted Residents by Family Doctors in Shenzhen Community Health Service Centers [J]. Chinese General Practice, 2023, 26(25): 3112-3117. |
[9] | ZHANG Yanjing, SONG Xiaokun. Ideas for the Diagnosis and Treatment of Multisystem Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors [J]. Chinese General Practice, 2023, 26(23): 2930-2935. |
[10] | ZHANG Yunxu, WANG Tingting, WEI Junling, XING Yanyun, SU Li. A Newly Discovered Disease Affecting Women's Physical and Mental Health: Research Status and Expert Consensus Interpretation of Persistent Genital Arousal Disorder [J]. Chinese General Practice, 2023, 26(23): 2830-2835. |
[11] | SHEN Junxi, ZHU Xing, CHEN Yunzhi, LI Wen. Novel Developments in Lung and Gut Microbiota and Their Cross-talk with the Development of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(20): 2548-2554. |
[12] | SU Afang, ZHU Guoling, ZHANG Yunshui, CHEN Shuohua, ZHAO Xiujuan, YANG Wenhao, WANG Yinjie, WANG Fengfei, XIN Yingying, WU Shouling, ZHANG Jie, JIANG Xiaozhong. Association between Baseline Fasting Plasma Glucose Levels and Risk of Acute Pancreatitis in Non-obese Population: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(18): 2203-2208. |
[13] | REN Yumei, XU Min, YE Meilei, ZHANG Qiu, HU Honglin. A Mutation in the Insulin Receptor Substrate 2 Gene May Be Associated with Maturity-onset Diabetes of the Young: a Case Report with Genetic Analysis [J]. Chinese General Practice, 2023, 26(18): 2301-2305. |
[14] | WANG Hai, WANG Zhuoli, PEI Honghong, PAN Longfei. Analysis of Risk Factors and Exploration of Predictors of Serious Cases of COVID-19 in Xi'an during the Period of 2021-2022 [J]. Chinese General Practice, 2023, 26(17): 2132-2137. |
[15] | SHEN Aomei, LU Qian, FU Xin, WEI Xiaoxia, BIAN Jingru, ZHANG Liyuan, QIANG Wanmin, PANG Dong. Constructing a Risk Prediction Model of Breast Cancer-related Lymphedema Based on a Meta-analysis of Prospective Cohort Studies [J]. Chinese General Practice, 2023, 26(17): 2078-2088. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||